Study to Identify and Determine Best Implementation Practices for Injectable Cabotegravir+Rilpivirine in the United States (US)
Clinical trial NCT04001803 · COMPLETED
Trial details
- NCT number
- NCT04001803
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-08
- Primary completion
- 2020-10-05
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.